rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1995-6-5
|
pubmed:abstractText |
The heterogeneity of tumor uptake is likely to substantially limit the effectiveness of metaiodobenzylguanidine (MIBG) therapy. This study was done to establish whether metabromobenzylguanidine (MBBG) can target neuroendocrine tumors and to provide intratumor biodistribution and uptake information in comparison to MIBG.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0161-5505
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
859-66
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7738664-3-Iodobenzylguanidine,
pubmed-meshheading:7738664-Animals,
pubmed-meshheading:7738664-Autoradiography,
pubmed-meshheading:7738664-Bromine Radioisotopes,
pubmed-meshheading:7738664-Bromobenzenes,
pubmed-meshheading:7738664-Guanidines,
pubmed-meshheading:7738664-Iodine Radioisotopes,
pubmed-meshheading:7738664-Iodobenzenes,
pubmed-meshheading:7738664-Mice,
pubmed-meshheading:7738664-Mice, Nude,
pubmed-meshheading:7738664-Neoplasm Transplantation,
pubmed-meshheading:7738664-PC12 Cells,
pubmed-meshheading:7738664-Pheochromocytoma,
pubmed-meshheading:7738664-Rats
|
pubmed:year |
1995
|
pubmed:articleTitle |
Assessing intratumor distribution and uptake with MBBG versus MIBG imaging and targeting xenografted PC12-pheochromocytoma cell line.
|
pubmed:affiliation |
Equipe de Microscopie Ionique, INSERM, Institut Gustave Roussy, Villejuif, France.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|